rwj 22108 has been researched along with Asthma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourcet, E; Conley, RA; Dodd, JH; Fabian, AC; Fenk, CJ; Gray-Nunez, Y; Kirchner, T; Moore, JB; Ritchie, DM; Schwender, CF | 1 |
| Ahmed, T; Anderson, DW; Capetola, RJ; Dodd, JH; Kirchner, T; Moore, JB; Ritchie, DM | 1 |
2 other study(ies) available for rwj 22108 and Asthma
| Article | Year |
|---|---|
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blocker.
Topics: Animals; Asthma; Bronchi; Bronchodilator Agents; Calcium Channel Blockers; Dogs; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Pyridines; Rabbits | 1993 |
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker.
Topics: Airway Obstruction; Airway Resistance; Animals; Antigens; Asthma; Bronchial Spasm; Bronchoconstriction; Calcium Channel Blockers; Consciousness; Dogs; Female; Gallopamil; Male; Nifedipine; Parasympatholytics; Pilocarpine; Pyridines; Sheep; SRS-A; Time Factors | 1993 |